Senescent tumor cells recruit CCR2-positive myeloid cells, enhancing hepatocellular carcinoma growth and worsening the prognosis of patients with hepatocellular carcinoma through NK cell inhibition [11]. Here, CCR2 is linked to hepatocellular carcinoma.